These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 16725245)

  • 1. The influence of significant others in complementary and alternative medicine decisions by cancer patients.
    Ohlén J; Balneaves LG; Bottorff JL; Brazier AS
    Soc Sci Med; 2006 Sep; 63(6):1625-36. PubMed ID: 16725245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing the role of evidence in patients' evaluation of complementary therapies: a quality study.
    Verhoef MJ; Mulkins A; Carlson LE; Hilsden RJ; Kania A
    Integr Cancer Ther; 2007 Dec; 6(4):345-53. PubMed ID: 18048882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Understanding the motivation for conventional and complementary/alternative medicine use among men with prostate cancer.
    Singh H; Maskarinec G; Shumay DM
    Integr Cancer Ther; 2005 Jun; 4(2):187-94. PubMed ID: 15911931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complementary and alternative medicine among advanced cancer patients enrolled on phase I trials: a study of prognosis, quality of life, and preferences for decision making.
    Hlubocky FJ; Ratain MJ; Wen M; Daugherty CK
    J Clin Oncol; 2007 Feb; 25(5):548-54. PubMed ID: 17290064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A population-based survey of complementary and alternative medicine use in men recently diagnosed with prostate cancer.
    Eng J; Ramsum D; Verhoef M; Guns E; Davison J; Gallagher R
    Integr Cancer Ther; 2003 Sep; 2(3):212-6. PubMed ID: 15035882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Men with prostate cancer: making decisions about complementary/alternative medicine.
    Boon H; Brown JB; Gavin A; Westlake K
    Med Decis Making; 2003; 23(6):471-9. PubMed ID: 14672107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alternative medicine or "alternative" patients: a qualitative study of patient-oriented decision-making processes with respect to complementary and alternative medicine.
    Caspi O; Koithan M; Criddle MW
    Med Decis Making; 2004; 24(1):64-79. PubMed ID: 15005956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of complementary and alternative medicine in Hawaii cancer patients.
    Gotay CC
    Hawaii Med J; 1999 Mar; 58(3):49-51, 54-5. PubMed ID: 10199098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The phenomenon of making decisions during the experience of early breast cancer.
    Halkett GK; Arbon P; Scutter SD; Borg M
    Eur J Cancer Care (Engl); 2007 Jul; 16(4):322-30. PubMed ID: 17587355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bridging the gap: decision-making processes of women with breast cancer using complementary and alternative medicine (CAM).
    Balneaves LG; Truant TL; Kelly M; Verhoef MJ; Davison BJ
    Support Care Cancer; 2007 Aug; 15(8):973-83. PubMed ID: 17609997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The decision-making experience among women diagnosed with stage I and II breast cancer.
    Sabo B; St-Jacques N; Rayson D
    Breast Cancer Res Treat; 2007 Mar; 102(1):51-9. PubMed ID: 16850245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Portrayals of treatment decision-making on popular breast and prostate cancer web sites.
    Seale C
    Eur J Cancer Care (Engl); 2005 May; 14(2):171-4. PubMed ID: 15842467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship between cancer locus of control and complementary and alternative medicine use by women diagnosed with breast cancer.
    Henderson JW; Donatelle RJ
    Psychooncology; 2003; 12(1):59-67. PubMed ID: 12548648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What is an exceptional cancer trajectory?: Multiple stakeholder perspectives on cancer trajectories in relation to complementary and alternative medicine use.
    Hök J; Forss A; Falkenberg T; Tishelman C
    Integr Cancer Ther; 2009 Jun; 8(2):153-63. PubMed ID: 19679624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. To be involved or not: factors that influence nurses' involvement in providing treatment decisional support in advanced cancer.
    Barthow C; Moss C; McKinlay E; McCullough L; Wise D
    Eur J Oncol Nurs; 2009 Feb; 13(1):22-8. PubMed ID: 19010732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment decision making in prostate cancer: patients' participation in complex decisions.
    Fischer M; Visser A; Voerman B; Garssen B; van Andel G; Bensing J
    Patient Educ Couns; 2006 Nov; 63(3):308-13. PubMed ID: 16965887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The experience of making treatment decisions for women with early stage breast cancer: a diagrammatic representation.
    Halkett GK; Arbon P; Scutter SD; Borg M
    Eur J Cancer Care (Engl); 2005 Jul; 14(3):249-55. PubMed ID: 15952969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors influencing men undertaking active surveillance for the management of low-risk prostate cancer.
    Davison BJ; Oliffe JL; Pickles T; Mroz L
    Oncol Nurs Forum; 2009 Jan; 36(1):89-96. PubMed ID: 19136342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of complementary therapies during chemotherapy: influence of patients' satisfaction with treatment decision making and the treating oncologist.
    Hann D; Allen S; Ciambrone D; Shah A
    Integr Cancer Ther; 2006 Sep; 5(3):224-31. PubMed ID: 16880427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Participation in medical decision making: the patients' perspective.
    Fraenkel L; McGraw S
    Med Decis Making; 2007; 27(5):533-8. PubMed ID: 17873253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.